Washington Lobbyist Reaps Contracts and Controversy

WASHINGTON—Two years ago, having decided to create a microelectronics center to help the area's sagging economy, the Rochester Institute of Technology realized it needed additional funds for construction and equipment. Its president, M. Richard Rose, contacted the Washington lobbying firm of Cassidy and Associates. Last summer Congress specified that $11.1 million from the Defense Department's budget go to the institute for a variety of purposes, including the new center. Today, smocked st

Written byElisabeth Carpenter
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Cassidy is the most well-known and, by all accounts, most successful of the firms that have taken up academia's urgent pleas for new research facilities. In doing so, they have fanned the flames of the debate over the propriety of "pork-barrel" politics in science, the process by which schools obtain federal money for facilities without any review of the scientific merits of their requests.

The firm was created in 1975 as Schlossberg, Cassidy and Associates. (Kenneth Schlossberg left in 1984.) Tufts University was an early—and satisfied—client, obtaining $10 million from Congress in 1977 for a veterinary school and $21 million in 1979 for a human nutrition research center. To date, the firm takes credit for helping to obtain $165 million worth of facilities for university clients.

Unquestionably, the academic community is in the midst of an infrastructure crisis. Science officials have estimated that up to $14 billion is needed to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies